APC8 Inhibitors

APC8 inhibitors, as a distinct chemical class, are not individually defined due to the absence of direct inhibitory molecules targeting APC8 specifically. However, the compounds listed above can affect the function of APC8 by modulating processes and pathways that are upstream or downstream of APC8's activity within the APC/C complex. They represent a diverse set of chemical structures, including small molecule inhibitors, peptide analogues, and kinase inhibitors.

Each of these compounds interacts with the cell cycle machinery in a unique way, influencing the activity of APC/C, of which APC8 is a critical part. For instance, ProTAME and TAME exert their effects by preventing the binding of essential APC/C activators, which are necessary for its ubiquitin ligase activity. In contrast, MLN4924 inhibits the neddylation process, which is essential for the activation of Cullin-RING ubiquitin ligases, a family of enzymes related to the function of the APC/C. The Aurora kinase and CDK inhibitors, such as Alisertib and Roscovitine, disrupt the cell cycle at various points, which can indirectly affect the activity of APC/C and consequently APC8. By inhibiting key regulators of the cell cycle, these compounds can lead to the stabilization of APC/C substrates and therefore impact the cell cycle progression.